Measuring people's changes in cognitive abilities is a better predictor of Alzheimer's disease than changes in biomarkers, researchers from the Benito Menni Complex Assistencial en Salut Mental, Barcelona, Spain, reported in Archives of General Psychiatry, a JAMA journal. The authors explain that changes in cerebrospinal fluid levels of some proteins or alterations in brain volume are examples of biomarkers that have helped researchers better understand how Alzheimer's disease develops and progresses - these biomarkers have also helped them determine whether treatments are effective...
Read from Source
|
